Steelworkers head into fourth week of strike, call on SNOLAB to bargain fair contract
May 28, 2024 09:15 ET
|
United Steelworkers union
Steelworkers head into fourth week of strike, call on SNOLAB to bargain fair contract.
Microplastics and human health: scientist sets record straight
May 28, 2024 08:38 ET
|
International Bottled Water Association
Alexandria, VA, May 28, 2024 (GLOBE NEWSWIRE) -- Common myths about the environmental impact of plastic and concerns about microplastics on human health are debunked by an independent scientist in...
Science World’s Creative Technology Gallery Wins Prestigious CASC Award for Innovation, Leadership and Impact in Making Science Accessible
May 24, 2024 11:00 ET
|
Science World
Vancouver, BC, May 24, 2024 (GLOBE NEWSWIRE) -- Science World is pleased to share that its Creative Technology Gallery, co-presented by Beedie and RBC, has won an award at this year’s Canadian...
Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease
May 23, 2024 14:00 ET
|
Hornet Therapeutics
Press Release Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease 4BIO Capital...
AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023
May 17, 2024 11:58 ET
|
AB Science
COMMUNIQUE RECTIFICATIF COMMUNIQUE RECTIFICATIF SUR LES COMPTES CONSOLIDES AU 31 DECEMBRE 2023 Paris, 17 mai 2024, 18h AB Science SA (Euronext - FR0010557264 -...
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences
May 17, 2024 07:00 ET
|
Chemomab Therapeutics
TEL AVIV, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for...
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités
May 15, 2024 14:16 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2023 ET LES EVENEMENTS CLEFS DE LA PERIODE Développement clinique Poursuite des...
AB Science reports its revenues for the year 2023 and provides an update on its activities
May 15, 2024 14:16 ET
|
AB Science
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional...
AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036
May 13, 2024 12:08 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LA DÉLIVRANCE D'UN BREVET EUROPÉEN POUR LE MASITINIB DANS LE TRAITEMENT DE LA MASTOCYTOSE SÉVÈRE AVEC UNE PROTECTION JUSQU'EN 2036 ...
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
May 13, 2024 12:08 ET
|
AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL 2036 Paris, May 13, 2024, 6pm CET AB Science SA...